Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of fluocinolone acetonide + hydroquinone + tretinoin cream for moderate to severe melasma
ChiCTR2100043798Phase 3Recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Sep 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tretinoin, fluocinolone and hydroquinone in melasma (3 arms), sponsored by First Hospital of China Medical University. Primary endpoints: Melasma Severity Scale and Safety. Started Sep 2020; status: recruiting.
02
Drugs
tretinoinfluocinolonehydroquinone
03
Conditions
melasma
Beyond the preview
Go deeper on ChiCTR2100043798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043798.